Drugs / Pasocovac
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05185817 | Nov 2021 → Jul 2022 | disease related to hematopoietic stem cell transplant | Tehran University of Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pasocovac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05185817 ↗ |